Conium maculatum
Conium maculatum · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Conium maculatum is a complex plant species known for its significant biochemical activities, including acting as an aldose-reductase inhibitor and an allelochemic agent. The plant contains the potent chemical coniine, which can be utilized in various preparations such as drops, extracts, infusions, and tablets. While it has shown potential in addressing conditions like cancer and skin diseases, it also possesses analgesic and allergenic properties. However, caution is necessary as its use is closely linked to adverse effects like dizziness and vertigo. Understanding its pharmacological profile is essential for managing its diverse biological impacts.
- Synonyms
- Conium Maculosum · Sium Conium · 17 more
- Common names
- Not available
- Family
- Apiaceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Common Names
Conium maculatum is a plant known by a diverse array of regional and common names across different cultures. In some areas, it is frequently referred to as Almindelig skarntyde or Astaperrexil handi. The plant also carries the name Baldıran, which highlights its presence in various linguistic traditions. Depending on the local dialect, it may be identified as Cecys or even Cecyt. These various monikers underscore the widespread recognition of this specific species throughout the world.
Sources: Catalogue of Life (COL)
Synonyms
Conium maculatum is a plant known by several different botanical names within scientific literature. It is frequently identified by the synonym Cicuta officinalis, reflecting its complex taxonomic history. Researchers also refer to this species as Conium ceretanum or Conium croaticum depending on the specific classification used. Additionally, the names Conium cicuta and Conium leiocarpum are recognized as valid synonyms for the plant. Understanding these various nomenclatures is essential for accurate identification and study.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Conium maculatum is a notable member of the kingdom Plantae. Within this vast biological realm, it is classified under the class Equisetopsida. This plant specifically belongs to the order Apiales, which helps define its evolutionary lineage. Moving down the taxonomic hierarchy, it is placed within the family Apiaceae. Finally, it is identified by its specific genus, Conium, which characterizes its unique botanical identity.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Apiales |
| Family | Apiaceae |
| Genus | Conium |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Conium maculatum exhibits a broad geographic presence across several diverse regions. Its distribution spans the African continent, including specific reaches such as Northern Africa and Algeria. Within the Macaronesia archipelago, the plant is commonly found throughout the Azores, Madeira, and the Canary Islands. The species also extends into Northeast Tropical Africa, with notable populations identified in Ethiopia. This widespread occurrence highlights the plant's ability to adapt to various environments across these territories.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Conium maculatum is a distinctive herbaceous plant characterized by its sturdy, self-supporting growth form. This species exhibits significant variability in size, with individual specimens reaching a minimum height of 0.5 meters. While some plants remain relatively short, others can grow to a height of approximately 1.79 meters. In optimal conditions, the plant can extend its stature to a maximum height of 3 meters. This range of development allows the herb to adapt to various environmental niches within its habitat.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Conium maculatum is a key ingredient in the multicomponent medicinal product known as Vertigoheel. Through advanced molecular profiling using UHPLC-ToF-MS, researchers have successfully identified the specific chemical markers that define this plant's contribution to the formula. Specifically, the analysis revealed that Conium maculatum contains the neuroactive alkaloid coniine, along with N-methylconiine. These characteristic constituents were quantified at nanogram-per-dose levels, confirming that the plant's bioactive properties are preserved in the final tablets and drops. Such precise characterization provides essential insights into the chemical composition of Vertigoheel and its potential mechanisms of action.
Conditions
Conium maculatum is noted in historical research for its use in the drug therapy of cancer. In ancient Egyptian traditions, the infusion of this plant was utilized to cure various skin diseases. Modern medicinal products like Vertigoheel incorporate the plant to help treat both vertigo and dizziness. Furthermore, the plant is identified as a source of substances that can trigger acute neurotoxic syndromes in humans.
Preparations
Conium maculatum is utilized in several different medicinal preparations according to the provided research. The plant is prepared as extracts to facilitate detailed molecular profiling through mass spectrometry. It is also prepared as an infusion, a method historically associated with ancient medicinal uses. Furthermore, Conium maculatum is prepared as drops within the multicomponent formulation known as Vertigoheel. Finally, the plant is prepared as tablets, ensuring its characteristic neuroactive constituents are present in the final dosage form.